Mitochondrial long chain fatty acid beta-oxidation in man and mouse.

[1]  D. Kurtz,et al.  Structural characterization of the mouse long-chain acyl-CoA dehydrogenase gene and 5′ regulatory region , 1998, Mammalian Genome.

[2]  C. Hoppel,et al.  Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry. , 2008, Clinical chemistry.

[3]  P. A. Wood,et al.  Homozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouse. , 2005, Molecular genetics and metabolism.

[4]  J. Vockley,et al.  A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 Deficiency , 2007 .

[5]  R. Wanders,et al.  An improved enzyme assay for carnitine palmitoyl transferase I in fibroblasts using tandem mass spectrometry. , 2007, Molecular genetics and metabolism.

[6]  J. Vockley,et al.  A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. , 2007, American journal of human genetics.

[7]  J. Rottman,et al.  Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. , 2006, American journal of physiology. Heart and circulatory physiology.

[8]  Jerry Vockley,et al.  Human Acyl-CoA Dehydrogenase-9 Plays a Novel Role in the Mitochondrial β-Oxidation of Unsaturated Fatty Acids* , 2005, Journal of Biological Chemistry.

[9]  C. Hoppel,et al.  Strategy for the isolation, derivatization, chromatographic separation, and detection of carnitine and acylcarnitines. , 2005, Analytical chemistry.

[10]  N. Manning,et al.  A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts , 1990, Journal of Inherited Metabolic Disease.

[11]  P. A. Wood,et al.  Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. , 2005, Molecular genetics and metabolism.

[12]  J. Vockley,et al.  Leaky beta-oxidation of a trans-fatty acid: incomplete beta-oxidation of elaidic acid is due to the accumulation of 5-trans-tetradecenoyl-CoA and its hydrolysis and conversion to 5-trans-tetradecenoylcarnitine in the matrix of rat mitochondria. , 2004, The Journal of biological chemistry.

[13]  R. Wanders,et al.  Changes in blood carnitine and acylcarnitine profiles of very long‐chain acyl‐CoA dehydrogenase‐deficient mice subjected to stress , 2004, European journal of clinical investigation.

[14]  D. Rabier,et al.  Recognition and management of fatty acid oxidation defects: A series of 107 patients , 1999, Journal of Inherited Metabolic Disease.

[15]  F. A. Wijburg,et al.  Disorders of mitochondrial fatty acyl-CoA β-oxidation , 1999, Journal of Inherited Metabolic Disease.

[16]  G. Dacremont,et al.  Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts , 1995, Journal of Inherited Metabolic Disease.

[17]  J. Rottman,et al.  Very-Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Mice , 2003, Circulation research.

[18]  A. Moorman,et al.  Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.

[19]  C. Roe,et al.  Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. , 2002, The Journal of clinical investigation.

[20]  R. Wanders,et al.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. , 2002, Pediatrics.

[21]  Piero Rinaldo,et al.  Fatty acid oxidation disorders. , 2002, Annual review of physiology.

[22]  C. Roe,et al.  Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[23]  D Matern,et al.  Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. , 2001, Human molecular genetics.

[24]  J. Ibdah,et al.  Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. , 2001, The Journal of clinical investigation.

[25]  J. Vockley,et al.  Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids. , 2000, Biochimica et biophysica acta.

[26]  A. Mathur,et al.  Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. , 1999, Circulation.

[27]  R. Wanders,et al.  Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[28]  A H van Gennip,et al.  Disorders of mitochondrial fatty acyl-CoA beta-oxidation. , 1999, Journal of inherited metabolic disease.

[29]  D. Kurtz,et al.  Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Wanders,et al.  Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. , 1998, The Journal of clinical investigation.

[31]  S. Denis,et al.  2,6-Dimethylheptanoyl-CoA is a specific substrate for long-chain acyl-CoA dehydrogenase (LCAD): evidence for a major role of LCAD in branched-chain fatty acid oxidation. , 1998, Biochimica et biophysica acta.

[32]  P. Divry,et al.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[33]  A. Strauss,et al.  Regulation of the human long chain acyl-CoA dehydrogenase gene by nuclear hormone receptor transcription factors. , 1997, Biochimica et biophysica acta.

[34]  H. Sprecher,et al.  Peroxisomes Contain Δ3,5,Δ2,4-Dienoyl-CoA Isomerase and thus Possess All Enzymes Required for the β-Oxidation of Unsaturated Fatty Acids by a Novel Reductase-Dependent Pathway , 1995 .

[35]  B. Poorthuis,et al.  Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. , 1995, Clinical chemistry.

[36]  William,et al.  Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. , 1995, The Journal of clinical investigation.

[37]  H. Sprecher,et al.  Peroxisomes contain delta 3,5,delta 2,4-dienoyl-CoA isomerase and thus possess all enzymes required for the beta-oxidation of unsaturated fatty acids by a novel reductase-dependent pathway. , 1995, Biochemical and biophysical research communications.

[38]  T. Hashimoto,et al.  Identification of Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Three Patients Previously Diagnosed with Long-Chain Acyl-CoA Dehydrogenase Deficiency , 1993, Pediatric Research.

[39]  T. Aoyama,et al.  A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. , 1993, Biochemical and biophysical research communications.

[40]  D. Hale,et al.  An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. , 1990, Analytical biochemistry.

[41]  J. Knudsen,et al.  Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. , 1990, The Biochemical journal.

[42]  T Hashimoto,et al.  Purification and properties of rat liver acyl-CoA dehydrogenases and electron transfer flavoprotein. , 1981, Journal of biochemistry.